Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2016
At a glance
- Drugs MK 2048/vicriviroc (Primary) ; MK 2048; Vicriviroc
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 15 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 15 Feb 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 18 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.